Profit500

2016 - #92 - BioSyent

Acquires and licenses pharmaceutical products to bring to market in Canada

Company Profile

Founded 2006
Chief Executives René Goehrum
Head Office Toronto, Ont.
Website www.biosyent.com
Stock Ticker TSX-V:RX

 

Company Financials

5-Year Growth 815
Exports as % of Sales 8
Employees 2015 41
Revenue Range 2015 10–20 m

 

Read More